Acknowledgement
Supported by : Wonkwang University
References
- Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161(4): 626-633. https://doi.org/10.1093/infdis/161.4.626
- Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 2000; 29(3): 559-578. https://doi.org/10.1016/S0889-8553(05)70130-8
- Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, Shimizu N, Tatematsu M. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 1998; 58(10): 2067-2069.
- Maruta F, Ota H, Genta RM, Sugiyama A, Tatematsu M, Katsuyama T, Kawasaki S. Role of N-methyl-N-nitrosourea in the induction of intestinal metaplasia and gastric adenocarcinoma in Mongolian gerbils infected with Helicobacter pylori. Scand J Gastroenterol 2001; 36(3): 283-290. https://doi.org/10.1080/00365520118612
- Asaka M, Sugiyama T, Kato M, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter 2001; 6(3): 254-261. https://doi.org/10.1046/j.1523-5378.2001.00037.x
- Salih BA, Abasiyanik MF, Saribasak H, Huten O, Sander E. A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology. Dig Dis Sci 2005; 50(8): 1517-1522. https://doi.org/10.1007/s10620-005-2871-7
- Maruta F, Sugiyama A, Ishizone S, Miyagawa S, Ota H, Katsuyama T. Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbils. J Gastroenterol 2005; 40(1): 104-105. https://doi.org/10.1007/s00535-004-1501-z
- Misiewicz JJ, Harris AW, Bardhan KD, Levi S, O'Morain C, Cooper BT, Kerr GD, Dixon MF, Langworthy H, Piper D. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut 1997; 41(6): 735-739. https://doi.org/10.1136/gut.41.6.735
- Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ; European Helicobacter Study Group. Management of Helicobacter pylori infection--the Maastricht IV/Florence Consensus Report. Gut 2012; 61(5): 646-664. https://doi.org/10.1136/gutjnl-2012-302084
- Midolo PD, Lambert JR, Turnidge J. Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 1996; 11(3): 290-292. https://doi.org/10.1111/j.1440-1746.1996.tb00078.x
- Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010; 59(8): 1143-1153. https://doi.org/10.1136/gut.2009.192757
- Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y; Study Group participants. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62(1): 34-42. https://doi.org/10.1136/gutjnl-2012-302254
- Buenz EJ, Bauer BA, Schnepple DJ, Wahner-Roedler DL, Vandell AG, Howe CL. A randomized Phase I study of Atuna racemosa: a potential new anti-MRSA natural product extract. J Ethnopharmacol 2007; 114(3): 371-376. https://doi.org/10.1016/j.jep.2007.08.027
- Liu CS, Cham TM, Yang CH, Chang HW, Chen CH, Chuang LY. Antibacterial properties of Chinese herbal medicines against nosocomial antibiotic resistant strains of Pseudomonas aeruginosa in Taiwan. Am J Chin Med 2007; 35(6): 1047-1060. https://doi.org/10.1142/S0192415X07005508
- Franceschi F, Cazzato A, Nista EC, Scarpellini E, Roccarina D, Gigante G, Gasbarrini G, Gasbarrini A. Role of probiotics in patients with Helicobacter pylori infection. Helicobacter 2007; 12(Suppl 2): 59-63. https://doi.org/10.1111/j.1523-5378.2007.00565.x
- Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, Song IS. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter 2008; 13(4): 261-268. https://doi.org/10.1111/j.1523-5378.2008.00601.x
- Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997; 41(1): 49-55. https://doi.org/10.1136/gut.41.1.49
- Coconnier MH, Lievin V, Bernet-Camard MF, Hudault S, Servin AL. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 1997; 41(5): 1046-1052. https://doi.org/10.1128/AAC.41.5.1046
- Coconnier MH, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998; 64(11): 4573-4580.
- Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, Corthesy-Theulaz I. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999; 60(3): 203-209. https://doi.org/10.1159/000007660
- Liu H, Rahman A, Semino-Mora C, Doi SQ, Dubois A. Specific and sensitive detection of H. pylori in biological specimens by real-time RT-PCR and in situ hybridization. PLoS One 2008; 3(7): e2689. https://doi.org/10.1371/journal.pone.0002689
- Moon DI, Shin EH, Oh HG, Oh JS, Hong S, Chung Y, Kim O. Usefulness of a Helicobacter pylori stool antigen test for diagnosing H. pylori infected C57BL/6 mice. Lab Anim Res 2013; 29(1): 27-32. https://doi.org/10.5625/lar.2013.29.1.27
- Lee H-A, Hong S, Oh H-G, Park S-H, Kim Y-C, Park H, Jeong GS, Kim O. Antibacterial Activity of Sanguisorba officinalis against Helicobacter pylori. Lab Anim Res 2010; 26(3): 257-263. https://doi.org/10.5625/lar.2010.26.3.257
- Lee H-A, Hong S, Oh H-G, Park S-H, Kim Y-C, Jeong G-S, Kim O. In vitro and in vivo Antibacterial Activities of Cinnamomum cassia Extracts Against Helicobacter pylori. Lab Anim Res 2010; 26(1): 21-29. https://doi.org/10.5625/lar.2010.26.1.21
- Kreuning J, Lindeman J, Biemond I, Lamers CB. Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J Clin Pathol 1994; 47(3): 227-231. https://doi.org/10.1136/jcp.47.3.227
- Vandenbergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 1993; 12(1-3): 221-237. https://doi.org/10.1111/j.1574-6976.1993.tb00020.x
- Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000; 130(2S Suppl): 396S-402S. https://doi.org/10.1093/jn/130.2.396S
- Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, Gasbarrini G, Gasbarrini A. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000; 14(12): 1625-1629. https://doi.org/10.1046/j.1365-2036.2000.00885.x
- Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 2004; 70(1): 518-526. https://doi.org/10.1128/AEM.70.1.518-526.2004
- Sgouras DN, Panayotopoulou EG, Martinez-Gonzalez B, Petraki K, Michopoulos S, Mentis A. Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice. Clin Diagn Lab Immunol 2005; 12(12): 1378-1386. https://doi.org/10.1128/CDLI.12.12.1378-1386.2005
- Lionetti E, Miniello VL, Castellaneta SP, Magista AM, de Canio A, Maurogiovanni G, Ierardi E, Cavallo L, Francavilla R. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 2006; 24(10): 1461-1468. https://doi.org/10.1111/j.1365-2036.2006.03145.x
- Ryan KA, Daly P, Li Y, Hooton C, O'Toole PW. Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J Antimicrob Chemother 2008; 61(4): 831-834. https://doi.org/10.1093/jac/dkn040
- Ki MR, Ghim SY, Hong IH, Park JK, Hong KS, Ji AR, Jeong KS. In vitro inhibition of Helicobacter pylori growth and of adherence of cagA-positive strains to gastric epithelial cells by Lactobacillus paraplantarum KNUC25 isolated from kimchi. J Med Food 2010; 13(3): 629-634. https://doi.org/10.1089/jmf.2009.1265
- Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2001; 47(5): 709-710. https://doi.org/10.1093/jac/47.5.709
- Salas-Jara MJ, Sanhueza EA, Retamal-Diaz A, Gonzalez C, Urrutia H, Garcia A. Probiotic Lactobacillus fermentum UCO- 979C biofilm formation on AGS and Caco-2 cells and Helicobacter pylori inhibition. Biofouling 2016; 32(10): 1245-1257. https://doi.org/10.1080/08927014.2016.1249367
- Song HY, Zhou L, Liu DY, Yao XJ, Li Y. What Roles Do Probiotics Play in the Eradication of Helicobacter pylori? Current Knowledge and Ongoing Research. Gastroenterol Res Pract 2018; 2018: 9379480.
Cited by
- Anti- Helicobacter pylori activity of acomplex mixture of Lactobacillus paracasei HP7 including the extract of Perilla frutescens var. acuta and Glycyrrhiza glabra vol.36, pp.None, 2018, https://doi.org/10.1186/s42826-020-00073-x
- Impact of Dietary Patterns on H. pylori Infection and the Modulation of Microbiota to Counteract Its Effect. A Narrative Review vol.10, pp.7, 2018, https://doi.org/10.3390/pathogens10070875